Temocapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor classified as a prodrug, which is primarily prescribed for the management of hypertension. As a prodrug, it undergoes hydrolysis… Read more
Temocapril hydrochloride is an angiotensin-converting enzyme (ACE) inhibitor classified as a prodrug, which is primarily prescribed for the management of hypertension. As a prodrug, it undergoes hydrolysis in vivo to form its active metabolite, temocaprilat, which exerts the therapeutic effect. This category provides a comprehensive selection of high-quality reference standards essential for pharmaceutical analytical testing and quality control. Laboratories utilize these compounds, including the active pharmaceutical ingredient (API), related pharmacopeial and non-pharmacopeial impurities such as oxidation products and nitroso derivatives, and stable isotope-labelled analogues like temocapril-d5, to ensure the accuracy of chromatographic assays. Researchers rely on these specialized materials for robust impurity profiling, method validation, and the reliable quantification of drug substances and their metabolites within complex matrices, ensuring compliance with strict regulatory requirements for pharmaceutical product development and stability testing.
